Percutaneous coronary intervention in left main coronary artery disease: the 13th consensus document from the

Francesco Burzotta1, Jens Flensted Lassen, Adrian P Banning

  • 1Institute of Cardiology, Catholic University of the Sacred Heart, Rome, Italy.

Insights

This review summarizes the 2017 European Bifurcation Club meeting, focusing on percutaneous coronary intervention (PCI) for left main coronary artery (LM) disease. It covers anatomy, diagnostics, and optimal PCI strategies for improved patient outcomes.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Medical Device Technology

Background:

  • Coronary artery disease involving the left main coronary artery (LM) poses significant risks.
  • Percutaneous coronary intervention (PCI) is a key treatment modality for LM disease.
  • The European Bifurcation Club (EBC) provides a platform for expert consensus and guideline updates.

Purpose of the Study:

  • To review and synthesize the latest data on coronary bifurcation interventions, with a focus on LM disease.
  • To discuss optimal strategies for PCI in LM disease, including anatomical assessment and procedural techniques.
  • To highlight the importance of team organization and catheterization laboratory setup for successful LM PCI.

Main Methods:

  • Review of current literature and expert discussions from the 2017 EBC meeting.
  • Analysis of key anatomical features, diagnostic modalities, and clinical outcome data relevant to LM PCI.
  • Critical evaluation of catheterization laboratory setup, device selection, and implantation techniques.

Main Results:

  • Key anatomical considerations and diagnostic approaches for LM disease were reviewed.
  • Optimal lesion preparation, drug-eluting stent (DES) implantation techniques, and strategies for unprotected LM PCI were discussed.
  • The impact of PCI team organization and performance on clinical outcomes was emphasized.

Conclusions:

  • Optimal management of LM disease requires a multidisciplinary approach and careful consideration of procedural details.
  • Evidence-based strategies for PCI in LM disease are evolving, emphasizing patient selection and technique.
  • Adherence to best practices in LM PCI is crucial for achieving favorable patient outcomes.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
510
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
298
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
411
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
728
Coronary Circulation01:21

Coronary Circulation

The heart, an organ critical to survival, gets nourishment not from the blood it pumps but from a separate circulation system known as coronary circulation. This is the shortest circulation in the body and is responsible for supplying the heart with the nutrients it needs to function effectively.
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
7.4K